Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study assesses inhaled corticosteroid plus montelukast compared with inhaled corticosteroid therapy alone for treatment of patients with chronic asthma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Mometasone Furoate; Montelukast

Criteria

Inclusion Criteria:

• Patient has decreased breathing capacity (when not taking asthma medicine) that improves after taking a fast-acting asthma inhaler

• Within one month of the first study visit, patient has been treated with a fast-acting asthma inhaler, and may be treated with a corticosteroid inhaler or an inhaler that combines a corticosteroid plus a bronchodilator

Exclusion Criteria:

• Patient is hypersensitive to inhaled beta-agonists, corticosteroids, leukotriene antagonists, or any of their components

• Has required an oral corticosteroid rescue for worsening asthma during the screening period